Related Experiment Video
Updated: Dec 29, 2025

03:47
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
1.4K
Calix[4]API-s: fully functionalized calix[4]arene-based facial active pharmaceutical ingredients
1Health Technology Incubation Center, Urmia University of Medical Sciences, Urmia, Iran. fazelnasuhi@gmail.com.
Molecular Diversity
|February 2, 2020
Summary
This review highlights 25 calix[4]arene-based cyclic tetramers with potent anticancer and anti-infective properties. These compounds show promise as novel therapeutic agents due to their unique structure and synergistic effects.
Area of Science:
- Medicinal Chemistry
- Supramolecular Chemistry
Background:
- Calix[4]arenes are versatile macrocyclic compounds with tunable properties.
- Functionalized calix[4]arenes can serve as scaffolds for developing novel bioactive molecules.
Purpose of the Study:
- To review fully functionalized facial calix[4]arene-based symmetrical and conical cyclic tetramers.
- To highlight their significant anticancer and anti-infective activities.
Main Methods:
- Literature review of 25 calix[4]arene derivatives.
- Analysis of structure-activity relationships for anticancer and anti-infective properties.
Main Results:
- Identified 25 calix[4]arene-based cyclic tetramers with significant biological activities.
- Demonstrated comparable efficacy to established therapeutic agents.
- Highlighted the role of the calixarene scaffold in replicating phenolic units.
Conclusions:
- Facial, conical calix[4]arene-based active pharmaceutical ingredients (calix[4]APIs) are effective bioactive agents.
- Multivalency and synergistic effects of replicated units contribute to their efficacy.
- These compounds represent promising candidates for drug development in oncology and infectious diseases.

![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)